To determine the sensitivity and specificity of the RAD51-FFPE test to identify functional HRD, we performed the RECAP test on viable, cryopreserved, matching tumor samples on the premise that the HRD status as determined by the RECAP test faithfully represented the functional HR status. This evidence concerns the gene RAD51 and neoplasm.